Frecuencia de staphylococcus aureus meticilinorresistente adquirido en la comunidad en un hospital de tercer nivel en Perú

Lucía Cabrejos-Hirashima; Camila Vives-Kufoy; Jaycia Inga-Salazar; Lizeth Astocondor; Noemi Hinostroza; Coralith García

doi:10.17843/rpmesp.2021.382.6867

Frecuencia de staphylococcus aureus meticilinorresistente adquirido en la comunidad en un hospital de tercer nivel en Perú

Translated title of the contribution: Frequency of community-acquired methicilin-resistant staphylococcus aureus in a tertiary care hospital in Peru

Lucía Cabrejos-Hirashima
, Camila Vives-Kufoy
, Jaycia Inga-Salazar
, Lizeth Astocondor
, Noemi Hinostroza
, Coralith García

Universidad Peruana Cayetano Heredia
Universidad Peruana Cayetano Heredia, Instituto de Medicina Tropical Alexander von Humboldt
Hospital Nacional Cayetano Heredia

Research output: Contribution to journal › Article › peer-review

4 Scopus citations

Abstract

In order to determine the frequency of community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA) isolates and to describe the antimicrobial resistance pattern and genotype, a cross-sectio-nal study was conducted in 2017 at the Hospital Nacional Cayetano Heredia in Lima, Peru. We found a MRSA prevalence of 46.1% in the 115 analyzed S. aureus isolates; most were reported from different secretions (26.4%) and blood (18.9%). We found high co-resistance (>75%) to clindamycin, erythromy-cin, gentamicin and ciprofloxacin. Regarding SSCmec typification, most of the isolates were identified as hospital-acquired MRSA (HA-MRSA) and a minority of them as CA-MRSA (2.6%). Despite its low prevalence when compared to other Latin American countries (27%), epidemiological surveillance is recommended to control local CA-MRSA dissemination.

Translated title of the contribution	Frequency of community-acquired methicilin-resistant staphylococcus aureus in a tertiary care hospital in Peru
Original language	Spanish
Pages (from-to)	313-317
Number of pages	5
Journal	Revista Peruana de Medicina Experimental y Salud Publica
Volume	38
Issue number	2
DOIs	https://doi.org/10.17843/rpmesp.2021.382.6867
State	Published - 1 Apr 2021

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.17843/rpmesp.2021.382.6867

Cite this

@article{7fae7c2cd2314c0598ef556902a36866,

title = "Frecuencia de staphylococcus aureus meticilinorresistente adquirido en la comunidad en un hospital de tercer nivel en Per{\'u}",

abstract = "In order to determine the frequency of community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA) isolates and to describe the antimicrobial resistance pattern and genotype, a cross-sectio-nal study was conducted in 2017 at the Hospital Nacional Cayetano Heredia in Lima, Peru. We found a MRSA prevalence of 46.1\% in the 115 analyzed S. aureus isolates; most were reported from different secretions (26.4\%) and blood (18.9\%). We found high co-resistance (>75\%) to clindamycin, erythromy-cin, gentamicin and ciprofloxacin. Regarding SSCmec typification, most of the isolates were identified as hospital-acquired MRSA (HA-MRSA) and a minority of them as CA-MRSA (2.6\%). Despite its low prevalence when compared to other Latin American countries (27\%), epidemiological surveillance is recommended to control local CA-MRSA dissemination.",

keywords = "Epidemiologi-cal surveillance, Methicillin-resistant Staphylococcus aureus, Peru (source: MeSH NLM), Prevalence, Staphylococcus aureus",

author = "Luc{\'i}a Cabrejos-Hirashima and Camila Vives-Kufoy and Jaycia Inga-Salazar and Lizeth Astocondor and Noemi Hinostroza and Coralith Garc{\'i}a",

year = "2021",

month = apr,

day = "1",

doi = "10.17843/rpmesp.2021.382.6867",

language = "Espa{\~n}ol",

volume = "38",

pages = "313--317",

journal = "Revista Peruana de Medicina Experimental y Salud Publica",

issn = "1726-4634",

number = "2",

}

Frecuencia de staphylococcus aureus meticilinorresistente adquirido en la comunidad en un hospital de tercer nivel en Perú. / Cabrejos-Hirashima, Lucía; Vives-Kufoy, Camila; Inga-Salazar, Jaycia et al.
In: Revista Peruana de Medicina Experimental y Salud Publica, Vol. 38, No. 2, 01.04.2021, p. 313-317.

Research output: Contribution to journal › Article › peer-review

TY - JOUR

T1 - Frecuencia de staphylococcus aureus meticilinorresistente adquirido en la comunidad en un hospital de tercer nivel en Perú

AU - Cabrejos-Hirashima, Lucía

AU - Vives-Kufoy, Camila

AU - Inga-Salazar, Jaycia

AU - Astocondor, Lizeth

AU - Hinostroza, Noemi

AU - García, Coralith

PY - 2021/4/1

Y1 - 2021/4/1

N2 - In order to determine the frequency of community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA) isolates and to describe the antimicrobial resistance pattern and genotype, a cross-sectio-nal study was conducted in 2017 at the Hospital Nacional Cayetano Heredia in Lima, Peru. We found a MRSA prevalence of 46.1% in the 115 analyzed S. aureus isolates; most were reported from different secretions (26.4%) and blood (18.9%). We found high co-resistance (>75%) to clindamycin, erythromy-cin, gentamicin and ciprofloxacin. Regarding SSCmec typification, most of the isolates were identified as hospital-acquired MRSA (HA-MRSA) and a minority of them as CA-MRSA (2.6%). Despite its low prevalence when compared to other Latin American countries (27%), epidemiological surveillance is recommended to control local CA-MRSA dissemination.

AB - In order to determine the frequency of community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA) isolates and to describe the antimicrobial resistance pattern and genotype, a cross-sectio-nal study was conducted in 2017 at the Hospital Nacional Cayetano Heredia in Lima, Peru. We found a MRSA prevalence of 46.1% in the 115 analyzed S. aureus isolates; most were reported from different secretions (26.4%) and blood (18.9%). We found high co-resistance (>75%) to clindamycin, erythromy-cin, gentamicin and ciprofloxacin. Regarding SSCmec typification, most of the isolates were identified as hospital-acquired MRSA (HA-MRSA) and a minority of them as CA-MRSA (2.6%). Despite its low prevalence when compared to other Latin American countries (27%), epidemiological surveillance is recommended to control local CA-MRSA dissemination.

KW - Epidemiologi-cal surveillance

KW - Methicillin-resistant Staphylococcus aureus

KW - Peru (source: MeSH NLM)

KW - Prevalence

KW - Staphylococcus aureus

UR - https://www.scopus.com/pages/publications/85114002780

U2 - 10.17843/rpmesp.2021.382.6867

DO - 10.17843/rpmesp.2021.382.6867

M3 - Artículo

C2 - 34468582

AN - SCOPUS:85114002780

SN - 1726-4634

VL - 38

SP - 313

EP - 317

JO - Revista Peruana de Medicina Experimental y Salud Publica

JF - Revista Peruana de Medicina Experimental y Salud Publica

IS - 2

ER -

Frecuencia de staphylococcus aureus meticilinorresistente adquirido en la comunidad en un hospital de tercer nivel en Perú

Abstract

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this